sofidexFor patientsAre you a clinician? Clinical site

Meds & supplements  ›  Imetelstat

Medicine

Imetelstat

The following clinically significant adverse reactions are described elsewhere in the labeling:

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
  • 1.
  • INDICATIONS AND USAGE RYTELO is indicated for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia requiring 4 or more red blood cell units over 8 weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESA).
  • RYTELO is an oligonucleotide telomerase inhibitor indicated for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia requiring 4 or more red blood cell units over 8 weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESA).

What it is used for

RYTELO is indicated for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia requiring 4 or more red blood cell units over 8 weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESA).

Side effects, and when to stop

Who should not take it

None.

Storing it

Storage

Store vials refrigerated at 2°C to 8°C (36°F to 46°F) in original carton.

Do not freeze.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Imetelstat; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/imetelstat

APA 7th

sofidex. (2026, August 3). Imetelstat. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/imetelstat

AMA 11th

Imetelstat. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/imetelstat

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.